Otéves tapasztalataink BCG immunprofilaxissal felületes hólyagdaganatos betegekben.

Translated title of the contribution: 5-year experience with BCG immunoprophylaxis in superficial bladder cancer

I. Romics, D. Bach, C. Rüssel

Research output: Contribution to journalReview article

Abstract

Our 5-year experience with BCG in the tumor stage pTis, pTa and pT1, G I-II shows a lasting remission of 88.5% (73%) in 78 (26) patients treated with BCG preparation Pasteur (Connaught) after transurethral resection. A complete remission in patients with carcinoma in situ (12 patients) could be found in 92%. The local and systemic side-effects, which are of limited duration, are tolerable, well treatable and fully reversible.

Original languageHungarian
Pages (from-to)2275-2276, 2279-2281
JournalOrvosi hetilap
Volume133
Issue number36
Publication statusPublished - Sep 6 1992

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this